THIS IS A SYNOPSIS OF THE ITALIAN STUDY ON LITHIUM
The ALS Association Works with Investigators onFollow Up Study of Lithium for Treating ALS
[Quick Summary: An Italian study of 44 people reports that a 15-month trial found that daily doses of the drug lithium, used to treat bipolar disorder, significantly slowed the progression of ALS in patients also taking riluzole, the only FDA-approved for the treatment of Lou Gehrig’s disease.
The ALS Association is working with investigators and funding organizations to plan a follow up clinical study of lithium as a treatment for ALS.
The 15-month trial conducted on 44 people with amyotrophic lateral sclerosis, commonly known as Lou Gehrig’s disease, reported that the progressive neurodegenerative disease was slowed significantly in patients receiving daily doses of lithium along with riluzole, the only drug approved by the U.S. Food & Drug Administration for the treatment of ALS.
Francesco Fornai at the University of Pisa (Italy) with colleagues at the University of Novara (Italy) and the Santa Lucia Foundation in Rome, demonstrated that lithium was neuroprotective and increased survival in the mouse model of ALS. These promising results led to the clinical study.
IF WE (PALS-PEOPLE W/ ALS) WAIT AROUND FOR THE GOOD OLD USA TO DO A CLINICAL TRIAL-WELL YOU KNOW.......................
THE FULL REPORT CAN BE FOUND ON: